The average one-year price target for CapsoVision (NasdaqCM:CV) has been revised to $12.75 / share. This is an increase of 19.05% from the prior estimate of $10.71 dated February 21, 2026.
The price target is an average of many targets provided by analysts. The latest targets range from a low of $11.11 to a high of $14.70 / share. The average price target represents an increase of 69.44% from the latest reported closing price of $7.52 / share.
What is the Fund Sentiment?
There are 36 funds or institutions reporting positions in CapsoVision. This is an increase of 7 owner(s) or 24.14% in the last quarter. Average portfolio weight of all funds dedicated to CV is 0.00%, an increase of 2,782.93%. Total shares owned by institutions increased in the last three months by 89.99% to 767K shares.
What are Other Shareholders Doing?
Geode Capital Management holds 154K shares representing 0.33% ownership of the company. In its prior filing, the firm reported owning 115K shares , representing an increase of 25.43%. The firm increased its portfolio allocation in CV by 52.77% over the last quarter.
Northern Trust holds 23K shares representing 0.05% ownership of the company. In its prior filing, the firm reported owning 43K shares , representing a decrease of 88.77%. The firm decreased its portfolio allocation in CV by 75.95% over the last quarter.
Millennium Management holds 15K shares representing 0.03% ownership of the company.
Charles Schwab Investment Management holds 14K shares representing 0.03% ownership of the company. No change in the last quarter.
Virtu Financial holds 12K shares representing 0.03% ownership of the company.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
